Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.

Nat Commun 2019 07 18;10(1):3163. Epub 2019 Jul 18.

Melanoma Institute Australia, The University of Sydney, Sydney, NSW, 2065, Australia.

Knowledge of key drivers and therapeutic targets in mucosal melanoma is limited due to the paucity of comprehensive mutation data on this rare tumor type. To better understand the genomic landscape of mucosal melanoma, here we describe whole genome sequencing analysis of 67 tumors and validation of driver gene mutations by exome sequencing of 45 tumors. Tumors have a low point mutation burden and high numbers of structural variants, including recurrent structural rearrangements targeting TERT, CDK4 and MDM2. Significantly mutated genes are NRAS, BRAF, NF1, KIT, SF3B1, TP53, SPRED1, ATRX, HLA-A and CHD8. SF3B1 mutations occur more commonly in female genital and anorectal melanomas and CTNNB1 mutations implicate a role for WNT signaling defects in the genesis of some mucosal melanomas. TERT aberrations and ATRX mutations are associated with alterations in telomere length. Mutation profiles of the majority of mucosal melanomas suggest potential susceptibility to CDK4/6 and/or MEK inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-11107-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639323PMC
July 2019
10 Reads

Publication Analysis

Top Keywords

mucosal melanoma
12
drivers therapeutic
8
therapeutic targets
8
mucosal melanomas
8
landscape mucosal
8
mucosal
5
nf1 kit
4
kit sf3b1
4
braf nf1
4
sf3b1 tp53
4
genes nras
4
nras braf
4
spred1 atrx
4
sf3b1 mutations
4
mutations occur
4
occur commonly
4
chd8 sf3b1
4
hla-a chd8
4
mutated genes
4
atrx hla-a
4

References

(Supplied by CrossRef)

Z Chi et al.
BMC Cancer 2011

SJ Furney et al.
J. Pathol. 2013

JD Hintzsche et al.
Melanoma Res 2017

J Lyu et al.
J. Pathol. 2018

E Hodis et al.
Cell 2012

M Krauthammer et al.
Nat. Genet. 2012

NK Hayward et al.
Nature 2017

SP D’Angelo et al.
J. Clin. Oncol. 2017

J Yan et al.
Eur. J. Cancer 2018

L Si et al.
Eur. J. Cancer 2012

HS Kim et al.
Oncogene 2017

Similar Publications